AQP4 and neuromyelitis optica: A serum autoantibody biomarker, neuromyelitis optica (NMO)-immunoglobin G (IgG), targeting aquaporin 4 (AQP4) water channels, which is enriched in the foot processes of astrocytes, has been identified in the central pathogenesis of NMOSD.